Dr. Suzanne Skoda-Smith, MD | Seattle Children's Hospital

Skip to main content

Search
Profile

Suzanne Skoda-Smith, MD

Suzanne Skoda-Smith, MD

Suzanne Skoda-Smith, MD

Immunology
Academic Title:

Associate Professor, Assistant Program Director of the UWSOM Allergy and Immunology Fellowship Training Program

Offices & Contact Information

Location
Address
Contact
Seattle Children's

Primary office location

R-5441 - Immunology

4800 Sand Point Way NE

Seattle, WA 98105

Primary Phone:

(206)987-2482

Seattle Children's Research Institute

C9S - 7 - Immunology

1900 - 9th Ave

Seattle, WA 98101

Primary Phone:

(206)987-2482

Professional History

Board Certified:

Allergy and Immunology

Medical/Professional School:

University of Miami - Jackson Memorial Medical Center, Miami

Residency:

University of Florida, Gainsville, Pediatrics

Fellowship:

Children's Hospital of Alabama, Birmingham, Allergy and Immunology

Clinical Interests:

Primary Immunodeficiency Diseases, Hematopoetic Stem Cell Transplantation for Immunodeficiency, Secondary Immunodeficiency associated with Solid Organ Transplantation

Clinical care for patients with primary immunodeficiencies

Description of Research:

My clinical research has been focused on the delivery of care and new therapies to patients with primary immunodeficiency diseases, particularly those needing hematopoetic stem cell transplantation. I am particularly interested in how to bring the promise of new therapies currently in the laboratory setting, to reality in the clinical care arena. I also interface with clinicians skilled in the care of solid organ transplant patients who experience secondary immunodeficiency as a consequence of their transplant therapies.

Key Publications:

Elder ME, Skoda-Smith S, Kadlecek TA, Wang F, Wu J, Weiss A. Distinct T-cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of Zap-70. (2001) J Immunol 166:656-661.

Skoda-Smith S, Mehta P, Graham-Pole JG, Wingard JR. Treatment of post-transplant lymphoproliferatie disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab. (2001) Bone Marrow Transplantation 27:329-332.

Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM, Dale JK, Puck J, Davis J, Hall CG, Skoda-Smith S, Atkinson TP, Strauss SE, Lenardo MJ. Pleiotrophic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. (2002) Nature 419:395-399.

Aranda JM Jr, Scornik JC, Normann SJ, Lottenberg R, Schofield RS, Pauly DF, Miles M, Hill JA, Sleasman JW, Skoda-Smith S. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac vascular rejection: a case report. (2002) Transplantation 73: 907-910.

Find a Doctor or Researcher

Find a Doctor or Researcher

Name:

Latest News

Patrick Hagan: Waste Not, Want Not: The Key to Reducing Costs
10.8.09 — Washington Post

Seattle Children's president and COO Patrick Hagan discusses efforts to improve quality of care and lower costs.

Seattle Children's mobile science lab makes big debut
9.23.09 — King 5 TV

Feature story on the debut of Seattle Children’s mobile Science Adventure Lab.

P.E. accidents sending more kids to hospital
9.19.09 — King 5 TV

Dr. Tom Jinguji discusses P.E.-related injuries in children.